Mechanism of Synergy
Upstream hormonal + direct arousal.
The combination of PT-141 (Bremelanotide) and Kisspeptin represents a multi-pathway approach to biological age reduction. By simultaneously targeting distinct hallmarks of aging, this protocol achieves results that exceed the sum of its individual components.
PT-141 (Bremelanotide) primarily acts via melanocortin receptor agonist (mc3r/mc4r) that acts centrally in the hypothalamus to stimulate sexual arousal independent of vascular mechanisms., while Kisspeptin complements this by hypothalamic neuropeptide that activates gnrh neurons to stimulate lh/fsh release, regulating reproductive function and libido.. Together, they create a comprehensive cellular environment optimized for longevity and resilience.
Targeted Hallmarks of Aging
PT-141 (Bremelanotide) Targets
Systemic effectsKisspeptin Targets
Systemic effectsStart This Protocol
Alukard provides physician-supervised longevity protocols, including the PT-141 (Bremelanotide) + Kisspeptin stack, with GMP-certified compounds and comprehensive biomarker testing.
Get Physician ConsultationBegin Your Age Reversal Protocol for PT-141 (Bremelanotide) + Kisspeptin Stack
Alukard provides physician-supervised longevity protocols with GMP-certified compounds, biomarker testing, and personalized biological age reduction programs.
HIPAA Compliant · GMP Certified · Physician Supervised · Biomarker Testing